Magellan®

DEVICE3 trials

Sponsors

Arteriocyte, Inc.

Conditions

Acute BurnsCompartment SyndromeCritical Limb Ischemia (CLI)Peripheral Vascular Disease (PVD)

Phase 1

Safety Study of Bone Marrow Cell Concentrate Prepared Using the Magellan System to Treat Critical Limb Ischemia (CLI)

CompletedNCT01386216

Arteriocyte, Inc.Critical Limb Ischemia (CLI), Peripheral Vascular Disease (PVD)

Start: 2011-04-30End: 2016-12-31Updated: 2017-01-24

Phase I, Arteriocyte Magellan MAR01 Therapy - Compartment Syndrome and Battlefield Trauma

CompletedNCT01837264

Arteriocyte, Inc.Compartment Syndrome

Start: 2013-01-31End: 2017-01-31Updated: 2017-04-13

Using Autologous Platelet Rich Plasma (PRP) Gel to Treat Deep 2nd and 3rd Degree Burns

Arteriocyte, Inc.Acute Burns

Start: 2013-04-30End: 2018-03-31Target: 42Updated: 2018-01-09